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Abstract 
Background:  The  clinical  and  histological  presentation  of  spongiotic  dermatitis  and  its  inflammatory  infiltrates  warrant  further 
investigation. In this case documentation of a patient with cutaneous spongiotic reactivity, we aim to characterize antigen presenting 
cells,  as  well  as  the  skin-specific  cutaneous  lymphocyte  antigen  population  by  multiple  techniques.  Case  report:  A  30  year  old 
Caucasian female presented with a two week history of blistering and erosions around the vaginal, rectal and axillary areas. Material 
and  Methods:  We  utilized  hematoxylin  and  eosin  histology,  direct  immunofluorescence,  immunohistochemistry  and  confocal 
microscopy methods to evaluate the immune reaction patterns of the cutaneous inflammatory cells. Results: In the primary histologic 
areas of spongiotic dermatitis, a mixed population of B and T lymphocytes was seen. Ki-67 antigen proliferative index staining was 
accentuated in these areas, correlating with the presence of large numbers of epidermal and dermal antigen presenting cells. Among the 
antigen presenting cell population, we detected strong positivities with CD1a, Factor XIIIa,
 myeloid/hystoid antigen, S100, HAM-56, and 
CD68.  Interestingly,  immunoglobulins  G,  D  and  M and Complement factors C1q and C3 were also strongly expressed in antigen 
presenting cell areas, including positivity within the spongiotic epidermis and around dermal vessels. Conclusions: We document a 
heterogeneous population of B and T lymphocytes and the presence of multiple classes of antigen presenting cells, immunoglobulins and 
complement in and surrounding histologically spongiotic areas; these findings further correlated with increased levels of expression of 
Ki-67. 
 
Streszczenie 
Wstęp: Kliniczna i histologiczna prezentacja spongiozy w skórze i nacieków zapalnych wymaga dalszych badań. W tej dokumentacji 
przypadku pacjenta z reaktywną skórną spongiozą, staramy się scharakteryzować komórki prezentujące antygen, a takŜe specyficzne dla 
skóry  antygeny  skórnych  populacji  limfocytów,  poprzez  wykorzystanie  wielu  technik.  Opis  przypadku:  U  30-letniej  kobiety  rasy 
kaukaskiej  oceniano  dwutygodniową  historię  pęcherzy  i  nadŜerek  zlokalizowanych  na  całym  obszarze  pochwy,  odbytu  i  okolicy 
pachwin.  Materiał  i  Metody:  Wykorzystano  obrazy  histologiczne  z  hematoksyliną  i  eozyną,  immunofluorescencję  bezpośrednią, 
badanie  immunohistochemiczne  i  mikroskopię  konfokalną  jako skale oceny immunologicznych wzorców reakcji skórnych komórek 
zapalnych. Wyniki: W głównych histologicznych obszarach spongiozy, zapalenia skóry, obserwowano mieszaną populację limfocytów 
B  i  T.  Ki-67  –  antygenowy  wskaźnik  proliferacji  barwienia  korelował  w  naskórku  i  skórze  z  obecnością  duŜej  liczby  komórek 
prezentujących antygen. Wśród populacji komórek prezentujących antygen, wykryliśmy silnie pozytywną reakcję z CD1a, czynnikiem 
XIII, antygenem myeloid/hystoid, S100, HAM-56 i CD68. Co ciekawe, immunoglobuliny G, D i M oraz dopełniacz C1q i C3 były 
równie mocno wyraŜone w obszarach komórek prezentujących antygen, w tym pozytywnie w obszarach spongiozy naskórka i skóry  
oraz wokół naczyń skórnych. Wnioski: Udokumentowaliśmy heterogeniczną populację limfocytów B i T oraz obecność wielu klas 
komórek prezentujących antygen, immunoglobuliny i komponent w histologicznych obszarach spongiozy; te wyniki dalej korelowły ze 
wzrostem poziomu ekspresji Ki-67. 
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Introduction:  
Eczema  is  a  common  skin  condition, 
histologically  manifested  as  a  spongiotic  dermatitis. 
Patients experience intense pruritis that, if not controlled, 
can  lead  to  secondary  excoriation,  with  resultant 
infection  and  scarring.  The  first  manifestation  of  this 
condition may occurs at young ages. Eczema predilects 
male patients at all ages [1-3]. Classically, it presents on 
the  abdomen,  chest  or  buttocks.  Head  and  scalp 
presentations  are  unusual.  A  hereditary  component  has 
been  postulated  to  contribute  to  the  disease 
etiopathogenesis.  An  individual  affected  with  eczema 
experiences  itching  or  pain;  these  symptoms  are 
accompanied  by  cutaneous  inflammation,  clinically 
manifested as the classic skin rash [1-3]. The rash may 
also  develop  fluid-filled  blisters  [1-3].  Other  clinical 
causes of spongiotic dermatitis include  allergic contact 
or systemic reactions to foods, plants, metals, dyes and 
medications.  Infants  may  develop spongiotic dermatitis 
via an allergic contact diaper rash.  
Other clinical causes of a spongiotic dermatitis 
include  environmental  irritants,  perfumes,  smoke,  and 
solvents;  stress,  hormone  fluctuations,  exposure  to 
UVA/UVB  solar  radiation  (especially  if  the  patient  is 
photosensitive),  and  climate  changes  [1-3].  Spongiotic 
dermatitis may initially be identified by its characteristic 
erythematous  rash.  If  untreated,  the  condition  may 
progresses and become chronic; the rash may darken in 
color  and  become  rough  and  crusty.  Exacerbated 
spongiotic dermatitis may display vesicles (small blisters 
filled  with  fluid)  or  bumpy,  erythematous  skin  with 
pronounced pruritis.  Topical medications are thus used 
to  reduce  both  itching  and  inflammation.  If  the 
symptoms can be controlled, the disease progression will 
often  be  halted;  thus,  the  possibility  of  permanent 
scarring is minimized [1-3]. 
If  presenting  pruritis is not accompanied by a 
significant  rash,  then  a  menthol-based  cream  or  lotion 
may  be  utilized  [1-3].    If  the  pruritis  is  thus  not 
controlled,  or  if  severe  symptoms  exist,  then  a  topical 
corticosteroid  may  be  prescribed.  The  topical 
corticosteroid  will  address  both  pruritis  and 
inflammation.  If  topical  treatments  are  ineffective,  a 
prescription for an oral corticosteroid such as prednisone 
may be given to the patient. Some patients also report 
that taking Vitamin A or fish oil has provided relief from 
symptoms.  Keeping  the  affected  area  moist  with  any 
kind  of  non-irritating  lotion  or  cream  is  useful  in 
reducing irritation. In our patient, a topical moisturizer 
and  topical  corticosteroid  were  prescribed  with 
improvement of her lesions [1-3]. 
 
Case report:  
A  30  year  old  Caucasian  female  presented  in 
consultation to the dermatologist with two week history 
of  blistering  and  erosions  in  the  vaginal,  rectal  and 
axillary  areas.  The  clinical  history  was  relevant  for 
childhood  allergies.  No  previous  adult  history  of 
allergies  to  food,  deodorants,  sanitary  towels  or 
cosmetics  was  noted.  The  clinical  examination 
demonstrated  vesicles  and  erosions  in  erythematous, 
edematous areas. The history and clinical examinations 
for sexually transmitted diseases were negative. 
Methods:  
We performed two lesional skin biopsies from 
clinical  blisters.  The  first  biopsy  was  fixed  in  10% 
buffered  formalin,  and  submitted  for  hematoxylin  and 
eosin  (H&E)  and  periodic  acid  Schiff  (PAS) 
examination,  as  well  as  for  immunohistochemistry 
(IHC).  The  second  biopsy  was  placed  in  Michel’s 
transport  medium,  and  submitted  for  direct 
immunofluorescence  (DIF).  The  H&E,  IHC  and  DIF 
studies  and  stains  were  performed  as  previously 
described [4-8].  
 
Results:  
Examination  of  the  H&E  tissue  sections 
demonstrated diffuse, florid epidermal spongiosis. Serum 
scale crust was present, and intraepidermal Langerhans 
cell  microabscesses  were  noted.  Early  evidence  of  a 
subepidermal  blistering  disorder  was  seen,  although 
frank  blister  formation  was  not  observed.  The  dermis 
displayed a florid, superficial and deep, perivascular and 
interstitial  infiltrate  of  lymphocytes,  histiocytes, 
eosinophils,  neutrophils  and  mast  cells.  Plasma  cells 
were rare. No definitive evidence of an infectious, or a 
neoplastic  process  was  observed.  Focal,  dermal 
perivascular leukocytoclastic debris was noted, but frank 
vasculitis was not appreciated (fig. 1,2,3).  
 
Direct immunofluorescence (DIF): was performed, and 
evaluated  via  the  following  grading  system:  (+)  weak 
positive  to  (++++)  strong  positive,  and  (-)  negative. 
Results  of  the  DIF  were  IgG  (+,  Intracytoplasmic 
epidermal  keratinocytic,  and  dermal  perivascular); 
IgG4(-);  IgA(-);  IgM(-);  IgD(-);  IgE  (-); 
Complement/C1q(++, Focal BMZ and superficial dermal 
perivascular);  Complement/C3(++,  Focal  BMZ  and 
superficial dermal perivascular); albumin (++++, diffuse, 
nonspecific  dermal)  and  fibrinogen  (++++,  focal 
epidermal and florid, diffuse dermal) (fig 2,3).  
 
Confocal  microscopy  (CFM):  We  performed  CFM 
examinations utilizing standard 20X and 40X objective 
lenses;  each  photoframe  included  an  area  of 
approximately  440  x  330  µm.  Images  were  obtained 
using EZ-1 image analysis software (Nikon, Japan).  
 
Discussion:  
Spongiotic dermatitis (SD) is often encountered 
in  routine  dermatology  and  dermatopathology  practice. 
Spongiosis  is  a  term  used  to  describe  the 
dermatopathologic appearance of an epidermis impacted 
by  intercellular  edema.  Resultant  spaces  are  present 
between epidermal keratinocytes, which may progress to 
intraepidermal  vesiculation.  The  pathophysiologic 
mechanism of spongiosis remains unknown. It has been 
proposed that keratinocyte apoptosis induced by T-cells 
affects  transmembrane  proteins  involved  in cell to cell 
adhesion; the protein alterations may then be responsible 
for  development  of  spongiosis  via  dermal  hydrostatic 
pressure  [1-3].  Additional  histologic  features  of 
spongiotic dermatitides include serum crust, lymphocytic 
exocytosis,  and  Langerhans  cell  microabscesses  within 
the epidermis.  
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Prior  studies  have  attempted  to  characterize  the 
inflammatory infiltrates present in spongiotic dermatitis 
[9-10].  A  predominant  T  lymphocyte  population  has 
been reported [9-10]. In this study, our findings were in 
agreement with several authors because we also detected 
a large population of T lymphocytes. However, we also 
found several CD1a, factor XIIIa, HAM-56 and CD68
 
positive cells. Consistent with our findings, other authors 
have  also  reported that immunoglobulin D may play a 
pathophysiologic  role  [11].  Interestingly,  we  found 
robust  B  and  T  lymphocyte  activity,  and  a  prominent 
antigen presenting cell (APC) population.  
Further, the reactive cell and cytokine combination has 
not  been  previously  highlighted  in  spongiotic 
dermatitides. The APCs participate in the initiation of the 
inflammatory  process  in  various  immune-mediated 
dermatoses,  via  activation  of  antigen  specific  T 
lymphocytes. The skin contains several different subsets 
of  APCs.  Non-professional  APCs  do  not  constitutively 
express  the  MHC  class  II  proteins  required  for 
interaction with naive T cells; these are expressed only 
upon stimulation of the non-professional APC by certain 
cytokines such as gamma interferon (IFN-γ).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  1.a  CD1a  positive  cells  in  the  epidermis  by  IHC  (brown  staining,  blue  arrow),  b.  H&E  sections  highlighting 
epidermal spongiosis, with widening of the spaces between keratinocytes (100X) (blue arrows). The black arrows highlight 
dermal papillary tip vascular microthrombi. c. Same as b, at higher magnification (400X). d. IHC showing strong positivity 
to  myeloid/histoid  antigen  in  the  area  of  spongiotic  epidermis  (brown  staining;  blue  arrows),  in  contradistinction  to 
markedly less staining at the specimen periphery, unaffected by the spongiosis (100X) (red arrow). e. Similar to d, at higher 
magnification  (400X)  Blue  arrow  indicates  positive  epidermal  myeloid/histoid  staining;  red  arrow  indicates  punctuate 
staining in a papillary dermal tip. f. Positive Complement/C3 IHC staining around a hair follicle periphery below the 
spongiosis (brown staining, blue arrow). g. HAM-56 positive IHC straining around papillary dermal tip vessels where the 
microthrombi in b and c were seen (brown staining, blue arrow). h and i  H & E staining shows inflammation around 
dermal  blood  vessels  at  lower  and  higher  magnifications,  respectively  (blue  arrows).  j.  Positive  IHC  staining  for 
Complement/C3 in the papillary dermis (blue arrow) and at the basement membrane zone of the skin (blue arrow); also, 
note fine, punctate deposits within the epidermis (red arrow). k and l. IgD positive IHC staining in deep papillary dermal 
blood vessels (brown staining, blue arrows). 
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Non-professional  APCs  in  the  skin  include 
dermal  fibrohistiocytic  cells  and  vascular  endothelial 
cells.  In our patient, we detected multiple professional 
and non-professional APCs, as well as broad B and T 
activated  lymphocytic  populations  in  relevant  areas. 
Indeed,  the  myeloid/hystiocyte  antigen  (reactive  with 
human cytoplasmic L1 antigen, or calprotectin) was very 
reactive in the zone of epidermal spongiosis, as well as in 
the dermis in proximity to this process [13,14].   
 
 
The  fact  that  we  found  complement  as  well  as 
immunoglobulins in the inflamed area indicates that the 
immune  response  in  an  spongiotic  dermatitis  may  be 
more complex than currently thought.  
Thus, we recommend future studies to further investigate 
these findings. 
In our case the primary clinical cause of the spongiotic 
dermatitis was not determined with certainty. The patient 
was treated with topical steroids and oral antihistamines, 
with  subsequent  complete  improvement  of  her 
dermatosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 a, Epidermal CD3 IHC positive cells (dark brown staining, red arrow). b. and c. Positive Ki-67 IHC staining, in b 
on  the  non-spongitic  edge  of  the  skin  biopsy  (minimal brown staining, red arrow); in c, note the markedly increased 
staining in the histologically spongiotic area (dark brown staining, red arrow). d. CD45 positive IHC staining, accentuated 
in superficial and deep dermal areas cells subjacent to the spongiotic process (brown staining, red arrows) (40X).  The 
CD45 positive staining included both CD3 and CD20 positive lymphocytes. e. Positive CD68 IHC staining on individual 
cells, grouped in the papillary dermis subjacent to the spongiosis (brown staining, red arrows). f. CD3 positive IHC staining 
on lymphocytes infiltrating eccrine glands subjacent to the spongiosis (brown staining, red arrows). g. DIF demonstrating 
positive staining with anti-human FITCI conjugated IgG, in perinuclear and cytoplasmic patterns in spongiotic epidermal 
keratinocytes (green staining, red arrow). h. Positive Complement/C1Q IHC staining, diffuse in the papillary dermis in 
surrounding papillary dermal tip blood vessels adjacent to the spongiotic process (brown staining, blue arrows). i. Positive 
CD8 IHC staining around the dermal papillary tip blood vessels (dark brown staining, red arrow). 
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Figure 3. a. H & E, highlighting fibrohistiocytic cells in the dermis (grey cells, blue arrows). b Many of the fibrohistiocytic 
cells were positive for Factor XIIIa (blue arrows). c. Positive S100 IHC staining on epidermal and dermal Langerhans cells 
(blue arrows). d through g Confocal microscopy(CFM). In d and f, staining for FITCI conjugated anti-human fibrinogen, 
showing in d shaggy linear staining at the basement membrane zone of the dermal/epidermal junction (yellow arrow). The 
white  stars  highlight  positive  net-like  staining,  likely  representing  fibrinogen  deposition  within  epidermal  Langerhans 
microabscesses.  The red arrow highlights scattered fibrinogen positive cells in the epidermis. The white arrow shows a 
strong papillary dermal positivity, subjacent to the primary epidermal spongiotic area. e. Shows positive epidermal nuclear 
counterstaining with Dapi (dark blue). f, Combined CFM staining of fibrinogen (green staining) and Dapi(blue staining). g, 
similar  to  f  in  black  and  white  relief,  highlighting  positive  fibrinogen  staining  on  epidermal  cells  and  cell  junctions.
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